127
Views
43
CrossRef citations to date
0
Altmetric
Original Research

Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression

, , , , &
Pages 4975-4990 | Published online: 03 Oct 2016

References

  • FerrariAJSomervilleAJBaxterAJGlobal variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literaturePsychol Med201343347148122831756
  • NemeroffCBThe burden of severe depression: a review of diagnostic challenges and treatment alternativesJ Psychiatric Res2007413–4189206
  • LeonardBEThe concept of depression as a dysfunction of the immune systemCurr Immunol Rev20106320521221170282
  • BrasnjevicISteinbuschHWSchmitzCMartinez-MartinezPDelivery of peptide and protein drugs over the blood-brain barrierProg Neurobiol200987421225119395337
  • NezafatiMHVojdanparastMNezafatiPAntidepressants and cardiovascular adverse events: a narrative reviewARYA Atheroscler201511529530426715935
  • LiuYShenSLiZCajaninstilbene acid protects corticosterone-induced injury in PC12 cells by inhibiting oxidative and endoplasmic reticulum stress-mediated apoptosisNeurochem Int201478435225193317
  • NakataniYTsujiMAmanoTNeuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neuronsPhytomedicine201421111458146525022209
  • WorkmanJLGobinathARKitayNFChowCBrummelteSGaleaLAParity modifies the effects of fluoxetine and corticosterone on behavior, stress response and hippocampal neurogenesisNeuropharmacology201610544345326808316
  • ZhangHYZhaoYNWangZLHuangYFChronic corticosterone exposure reduces hippocampal glycogen level and induces depression-like behavior in miceJ Zhejiang Univ Sci B2015161626925559957
  • ZhaoYMaRShenJSuHXingDDuLA mouse model of depression induced by repeated corticosterone injectionsEur J Pharmacol20085811–211312018184609
  • AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol2009411405918662800
  • MaheshwariRKSinghAKGaddipatiJSrimalRCMultiple biological activities of curcumin: a short reviewLife Sci200678182081208716413584
  • ZhuRWuXXiaoYSynergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell lineCancer Biother Radiopharm201328857958723808828
  • BhutaniMKBishnoiMKulkarniSKAnti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changesPharmacol Biochem Behav2009921394319000708
  • KulkarniSKBhutaniMKBishnoiMAntidepressant activity of curcumin: involvement of serotonin and dopamine systemPsychopharmacology2008201343544218766332
  • YuZFKongLDChenYAntidepressant activity of aqueous extracts of Curcuma longa in miceJ Ethnopharmacol2002831–216116512413724
  • DarlingtonCLDexanabinol: a novel cannabinoid with neuroprotective propertiesIDrugs200361097697914534855
  • JuttlerEPotrovitaITarabinVThe cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B)Neuropharmacology200447458059215380375
  • MaasAIMurrayGHenneyH3rdEfficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trialLancet Neurol200651384516361021
  • ShohamiENovikovMMechoulamRA nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the ratJ Neurotrauma19931021091198411215
  • Burgos-MoronECalderon-MontanoJMSalvadorJRoblesALopez-LazaroMThe dark side of curcuminInt J Cancer201012671771177519830693
  • JainSKGillMSPawarHSSureshSNovel curcumin diclofenac conjugate enhanced curcumin bioavailability and efficacy in streptococcal cell wall-induced arthritisIndian J Pharm Sci201476541542225425755
  • ZhangZYJiangMFangJEnhanced therapeutic potential of nano-curcumin against subarachnoid hemorrhage-induced blood-brain barrier disruption through inhibition of inflammatory response and oxidative stressMol Neurobiol Epub12262015
  • AggarwalNGoindiSPreparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal useJ Biomed Nanotechnol20139456457623621015
  • NevesARQueirozJFWekslerBRomeroIACouraudPOReisSSolid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein ENanotechnology2015264949510326574295
  • SinghISwamiRPoojaDJeengarMKKhanWSistlaRLactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targetingJ Drug Target201624321222326219519
  • YangXLiuYLiuCZhangNBiodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulinJ Biomed Nanotechnol20128583484222888755
  • WongHLChattopadhyayNWuXYBendayanRNanotechnology applications for improved delivery of antiretroviral drugs to the brainAdv Drug Del Rev2010624–5503517
  • RempeRCramerSHuwelSGallaHJTransport of Poly(n-butylcyanoacrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrityBiochem Biophys Res Commun20114061646921295549
  • FogerFHoyerHKafedjiiskiKThaurerMBernkop-SchnurchAIn vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoproteinBiomaterials200627345855586016919723
  • ZhuSHuangRHongMEffects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450Eur J Phar Sci2009375573580
  • WangJZhuRGaoBThe enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvantBiomaterials201435146647824099705
  • GregusAWintinkAJDavisACKalynchukLEEffect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male ratsBehav Brain Res2005156110511415474655
  • PorsoltRDBertinAJalfreMBehavioral despair in mice: a primary screening test for antidepressantsArchives Internationales de Pharmacodynamie et de Therapie19772292327336596982
  • LeeBHKimJLeeRMGintonin enhances performance of mice in rotarod test: Involvement of lysophosphatidic acid receptors and catecholamine releaseNeurosci Lett201661225626026706688
  • NatuMVde SousaHCGilMHEffects of drug solubility, state and loading on controlled release in bicomponent electrospun fibersInt J Pharm20103971–2505820599485
  • MohantyCSahooSKThe in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulationBiomaterials201031256597661120553984
  • WuMZhangHZhouCJiaHMaZZouZIdentification of the chemical constituents in aqueous extract of Zhi-Qiao and evaluation of its antidepressant effectMolecules20152046925694025913931
  • WangJZhuRSunDIntracellular uptake of curcumin-loaded solid lipid nanoparticles exhibit anti-inflammatory activities superior to those of curcumin through the NF-kappaB signaling pathwayJ Biomed Nanotechnol201511340341526307824
  • DaillyEChenuFRenardCEBourinMDopamine, depression and antidepressantsFundam Clin Pharmacol200418660160715548230
  • HassanzadehPHassanzadehAThe CB(1) receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcuminNeurochem Res20123751112112022311129
  • KokonaDThermosKSynthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathwaysExp Eye Res2015136455825989217
  • Colucci-D’AmatoLPerrone-CapanoCdi PorzioUChronic activation of ERK and neurodegenerative diseasesBioEssays200325111085109514579249
  • GourleySLWuFJTaylorJRCorticosterone regulates pERK1/2 map kinase in a chronic depression modelAnn N Y Acad Sci2008114850951419120149
  • AbbottNJBlood-brain barrier structure and function and the challenges for CNS drug deliveryJ Inherit Metab Dis201336343744923609350
  • AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
  • KulkarniSKDhirAAn overview of curcumin in neurological disordersIndian J Pharm Sci201072214915420838516
  • KulkarniSDhirAAkulaKKPotentials of curcumin as an antidepressantScientificWorldJournal200991233124119882093
  • VinkRNimmoAJMultifunctional drugs for head injuryNeurotherapeutics200961284219110197
  • WangJWangHZhuRLiuQFeiJWangSAnti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1beta transgenic mice subjected to the lipopolysaccharide-induced sepsisBiomaterials20155347548325890744
  • GastaldiLBattagliaLPeiraESolid lipid nanoparticles as vehicles of drugs to the brain: current state of the artEur J Pharm Biopharm201487343344424833004
  • GershkovichPQadriBYacovanAAmselemSHoffmanADifferent impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220Eur J Pharm Sci200731529830517560096
  • IqbalJHombachJMatuszczakBBernkop-SchnurchADesign and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitorJ Control Release20101471626920603165
  • GaoSLiWZouWH2S protects PC12 cells against toxicity of corticosterone by modulation of BDNF-TrkB pathwayActa Biochimica et Biophysica Sinica2015471191592426423115
  • SunXPShiZPanRLAntidepressant-like effects and mechanism of action of SYG in depression model in ratsNeuro Endocrinol Lett201435212913624878971
  • LiuDWangZGaoZEffects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stressBehav Brain Res201427111612124914461
  • WitkinJMLeuckeSThompsonLKFurther evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcuminCNS Neurol Disord Drug Targets201312449850523574162
  • XiongZEDongWGWangBYTongQYLiZYCurcumin attenuates chronic ethanol-induced liver injury by inhibition of oxidative stress via mitogen-activated protein kinase/nuclear factor E2-related factor 2 pathway in micePharmacogn Mag2015114470771526600714
  • QuiMSGreenSHPC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activityNeuron1992947057171382473
  • RooversKAssoianRKIntegrating the MAP kinase signal into the G1 phase cell cycle machineryBioEssays200022981882610944584
  • KaranianDABrownQBMakriyannisABahrBABlocking cannabi-noid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampusEur J Pharmacol20055081–3475615680253
  • MirantiCKBruggeJSSensing the environment: a historical perspective on integrin signal transductionNat Cell Biol200244E83E9011944041
  • LiuJQiaoWYangYRenLSunYWangSAntidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depressionJ Ethnopharmacol2012141125726422366432
  • KafaHWangJTRubioNTranslocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivoJ Control Release201622521722926809004